Amelioration of chemotherapy-induced toxicity by cotreatment with AcSDKP, a tetrapeptide inhibitor of hematopoietic stem cell proliferation. [electronic resource]
- Annals of the New York Academy of Sciences 1991
- 126-39 p. digital
Publication Type: Journal Article
0077-8923
10.1111/j.1749-6632.1991.tb17230.x doi
Animals Body Weight--drug effects Carcinoma, Non-Small-Cell Lung--drug therapy Carcinoma, Squamous Cell--drug therapy Cell Line Cyclophosphamide--therapeutic use Cytarabine--pharmacology Female Growth Inhibitors--therapeutic use Hematopoietic Stem Cells--drug effects Humans Immunologic Deficiency Syndromes--physiopathology Lung Neoplasms--drug therapy Mice Mice, Inbred BALB C Mice, Nude Neoplasm Transplantation Oligopeptides--pharmacology Transplantation, Heterologous